Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT

[1]  M. Li,et al.  Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma , 2011, Medical oncology.

[2]  Y. Kwong.  High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies , 2009, Bone Marrow Transplantation.

[3]  H. Lazarus,et al.  Donor lymphocyte infusions: the long and winding road: how should it be traveled? , 2008, Bone Marrow Transplantation.

[4]  İ. Zindancı,et al.  Extranodal NK/T cell lymphoma, nasal type. , 2008, European journal of dermatology : EJD.

[5]  K. Ohshima,et al.  Extranodal NK/T‐cell lymphoma: diagnosis and treatment cues , 2008, Hematological oncology.

[6]  T. Okamura,et al.  Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia , 2008, Cancer science.

[7]  S. Kako,et al.  Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation , 2007, American journal of hematology.

[8]  T. Yoshino,et al.  [Extranodal NK/T-cell lymphoma, nasal type]. , 2007, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[9]  Y. Kanda,et al.  Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer‐cell neoplasms , 2005, British journal of haematology.

[10]  K. Takenaka,et al.  Successful Treatment of Progressive NK cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions , 2002, International journal of hematology.